Literature DB >> 15331604

Direct binding of DNA by tumor suppressor menin.

Ping La1, Albert C Silva, Zhaoyuan Hou, Haoren Wang, Robert W Schnepp, Nieng Yan, Yigong Shi, Xianxin Hua.   

Abstract

Menin is a tumor suppressor that is mutated in patients with multiple endocrine neoplasia type I (MEN1), an inherited tumor-prone syndrome. Because there is no obvious conserved structural domain in menin that suggests a biochemical function, little is known as to how menin suppresses tumorigenesis. Although menin interacts with a variety of nuclear proteins including transcription factors, it is unknown whether menin itself can directly bind DNA. Here we show that menin directly binds to double-stranded DNA. It also binds a variety of DNA structures, including Y-structures, branched structures, and 4-way junction structures. The COOH terminus of menin mediates binding to DNA, but MEN1 disease-derived mutations in the COOH terminus abolish the ability of menin to bind DNA. Importantly, these MEN1 disease-related menin mutants also fail to repress cell proliferation as well as cell cycle progression at the G2/M phase. Furthermore, detailed mutagenesis studies indicate that positively charged residues in two nuclear localization signals mediate direct DNA binding as well as repression of cell proliferation. Collectively, these results demonstrate, for the first time, a novel biochemical activity of menin, binding to DNA, and link its DNA binding to the regulation of cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15331604      PMCID: PMC2858586          DOI: 10.1074/jbc.M409358200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Positional cloning of a novel Fanconi anemia gene, FANCD2.

Authors:  C Timmers; T Taniguchi; J Hejna; C Reifsteck; L Lucas; D Bruun; M Thayer; B Cox; S Olson; A D D'Andrea; R Moses; M Grompe
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

2.  Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling.

Authors:  H Kaji; L Canaff; J J Lebrun; D Goltzman; G N Hendy
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors.

Authors:  O Hessman; B Skogseid; G Westin; G Akerström
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

4.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Authors:  I Garcia-Higuera; T Taniguchi; S Ganesan; M S Meyn; C Timmers; J Hejna; M Grompe; A D D'Andrea
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

5.  Branch migration and Holliday junction resolution catalyzed by activities from mammalian cells.

Authors:  A Constantinou; A A Davies; S C West
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

6.  A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression.

Authors:  L Y Marmorstein; A V Kinev; G K Chan; D A Bochar; H Beniya; J A Epstein; T J Yen; R Shiekhattar
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

Review 7.  Multiple endocrine neoplasia type 1: new clinical and basic findings.

Authors:  D H Schussheim; M C Skarulis; S K Agarwal; W F Simonds; A L Burns; A M Spiegel; S J Marx
Journal:  Trends Endocrinol Metab       Date:  2001 May-Jun       Impact factor: 12.015

8.  The regulatory region of the human desmocollin 3 promoter forms a DNA four-way junction.

Authors:  P L Gadhavi; M D Greenwood; M Strom; I A King; R S Buxton
Journal:  Biochem Biophys Res Commun       Date:  2001-02-23       Impact factor: 3.575

Review 9.  Unwinding the molecular basis of the Werner syndrome.

Authors:  J Shen; L A Loeb
Journal:  Mech Ageing Dev       Date:  2001-07-15       Impact factor: 5.432

10.  Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line.

Authors:  L A Annab; R E Hawkins; G Solomon; J C Barrett; C A Afshari
Journal:  Breast Cancer Res       Date:  2000-02-21       Impact factor: 6.466

View more
  25 in total

1.  Interaction of MLL amino terminal sequences with menin is required for transformation.

Authors:  Corrado Caslini; Zhaohai Yang; Mohamad El-Osta; Thomas A Milne; Robert K Slany; Jay L Hess
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

Review 2.  In search of tumor suppressing functions of menin.

Authors:  Yuqing Yang; Xianxin Hua
Journal:  Mol Cell Endocrinol       Date:  2007-01-11       Impact factor: 4.102

3.  The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.

Authors:  Ya-Xiong Chen; Jizhou Yan; Karen Keeshan; Anthony T Tubbs; Haoren Wang; Albert Silva; Eric J Brown; Jay L Hess; Warren S Pear; Xianxin Hua
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

Review 4.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

5.  Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

Authors:  Akihiko Yokoyama; Michael L Cleary
Journal:  Cancer Cell       Date:  2008-07-08       Impact factor: 31.743

6.  Expression and subcellular localization of menin in human cancer cells.

Authors:  Feng Ren; Hong-Wei Xu; Yu Hu; Shuang-Hong Yan; Feng Wang; Bao-Wei Su; Qi Zhao
Journal:  Exp Ther Med       Date:  2012-03-29       Impact factor: 2.447

7.  Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c.

Authors:  Satyajit K Karnik; Christina M Hughes; Xueying Gu; Orit Rozenblatt-Rosen; Graeme W McLean; Yue Xiong; Matthew Meyerson; Seung K Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-29       Impact factor: 11.205

8.  Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.

Authors:  Ping La; Yuqing Yang; Satyajit K Karnik; Albert C Silva; Robert W Schnepp; Seung K Kim; Xianxin Hua
Journal:  J Biol Chem       Date:  2007-08-31       Impact factor: 5.157

Review 9.  Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors.

Authors:  Anelia Horvath; Constantine A Stratakis
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

10.  MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression.

Authors:  Frank E Erfurth; Relja Popovic; Jolanta Grembecka; Tomasz Cierpicki; Catherine Theisler; Zhen-Biao Xia; Tara Stuart; Manuel O Diaz; John H Bushweller; Nancy J Zeleznik-Le
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.